[Basics of gerontopharmaceutic therapy and the therapy of agitation in old age]. / Pharmakotherapie für Alterspatienten. Allgemeine Grundsätze und die Behandlung der Agitiertheit im Speziellen.
Praxis (Bern 1994)
; 98(21): 1211-7, 2009 Oct 21.
Article
in De
| MEDLINE
| ID: mdl-19844879
ABSTRACT
The biggest problem of gerontopharmaceutic therapy is polypharmacy, because it potentiates side effects and malcompliance. Best practice today includes instruction of long time patients in medication self management, which includes regular use of detailed taken medication lists. In gerontopharmaceutic therapy the following substances should be avoided anticholinergics, dopamin receptor stimulants, long acting oral antidiabetics, benzodiazepine (other then for substitution in low dose dependency, in anaesthesia or in palliative situations) and neuroleptics (other then for psychotic symptoms). In unspecific agitation with or without dementia the measure of first choice is adaption of the milieu, which may be supported by the prescription of a sedative non tricyclic antidepressive medication.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Psychomotor Agitation
/
Polypharmacy
/
Drug-Related Side Effects and Adverse Reactions
/
Geriatrics
/
Homes for the Aged
/
Nursing Homes
Type of study:
Guideline
Limits:
Aged
/
Humans
Country/Region as subject:
Europa
Language:
De
Journal:
Praxis (Bern 1994)
Journal subject:
MEDICINA
Year:
2009
Document type:
Article